These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer. Sahoo B; Arduini I; Drombosky KW; Kodali R; Sanders LH; Greenamyre JT; Wetzel R PLoS One; 2016; 11(6):e0155747. PubMed ID: 27271685 [TBL] [Abstract][Full Text] [Related]
6. Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils. Isas JM; Langen R; Siemer AB Biochemistry; 2015 Jun; 54(25):3942-9. PubMed ID: 26020223 [TBL] [Abstract][Full Text] [Related]
7. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors. Banerjee M; Datta M; Bhattacharyya NP Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155 [TBL] [Abstract][Full Text] [Related]
8. Binding, internalization and fate of Huntingtin Exon1 fibrillar assemblies in mitotic and nonmitotic neuroblastoma cells. Ruiz-Arlandis G; Pieri L; Bousset L; Melki R Neuropathol Appl Neurobiol; 2016 Feb; 42(2):137-52. PubMed ID: 26111612 [TBL] [Abstract][Full Text] [Related]
9. Formation and Structure of Wild Type Huntingtin Exon-1 Fibrils. Isas JM; Langen A; Isas MC; Pandey NK; Siemer AB Biochemistry; 2017 Jul; 56(28):3579-3586. PubMed ID: 28621522 [TBL] [Abstract][Full Text] [Related]
10. Nanoscale studies link amyloid maturity with polyglutamine diseases onset. Ruggeri FS; Vieweg S; Cendrowska U; Longo G; Chiki A; Lashuel HA; Dietler G Sci Rep; 2016 Aug; 6():31155. PubMed ID: 27499269 [TBL] [Abstract][Full Text] [Related]
12. Structural Basis of Huntingtin Fibril Polymorphism Revealed by Cryogenic Electron Microscopy of Exon 1 HTT Fibrils. Nazarov S; Chiki A; Boudeffa D; Lashuel HA J Am Chem Soc; 2022 Jun; 144(24):10723-10735. PubMed ID: 35679155 [TBL] [Abstract][Full Text] [Related]
13. Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease. Drombosky KW; Rode S; Kodali R; Jacob TC; Palladino MJ; Wetzel R Neurobiol Dis; 2018 Dec; 120():126-138. PubMed ID: 30171891 [TBL] [Abstract][Full Text] [Related]
14. A Targetable Self-association Surface of the Huntingtin exon1 Helical Tetramer Required for Assembly of Amyloid Pre-nucleation Oligomers. Mishra R; Gerlach GJ; Sahoo B; Camacho CJ; Wetzel R J Mol Biol; 2024 Jun; 436(12):168607. PubMed ID: 38734203 [TBL] [Abstract][Full Text] [Related]
15. Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance. Hoop CL; Lin HK; Kar K; Hou Z; Poirier MA; Wetzel R; van der Wel PC Biochemistry; 2014 Oct; 53(42):6653-66. PubMed ID: 25280367 [TBL] [Abstract][Full Text] [Related]
17. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease. Wetzel R Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927 [TBL] [Abstract][Full Text] [Related]
18. Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation. van der Wel PCA Biochem Soc Trans; 2024 Apr; 52(2):719-731. PubMed ID: 38563485 [TBL] [Abstract][Full Text] [Related]
19. Amplification of neurotoxic HTTex1 assemblies in human neurons. Chongtham A; Isas JM; Pandey NK; Rawat A; Yoo JH; Mastro T; Kennedy MB; Langen R; Khoshnan A Neurobiol Dis; 2021 Nov; 159():105517. PubMed ID: 34563643 [TBL] [Abstract][Full Text] [Related]
20. The polyglutamine domain is the primary driver of seeding in huntingtin aggregation. Skeens A; Siriwardhana C; Massinople SE; Wunder MM; Ellis ZL; Keith KM; Girman T; Frey SL; Legleiter J PLoS One; 2024; 19(3):e0298323. PubMed ID: 38483973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]